2019

Nemera News

  • PATIENT SAFETY: KEY DRIVER TO PRESERVATIVE-FREE NASAL SPRAY DEVELOPMENT

    Seen in the press: Nemera’s Advancia PF featured in November ‘Pulmonary and Nasal Delivery’

    November 12, 2019

    ‘Pulmonary and Nasal Delivery’ magazine features Nemera’s Preservative-Free nasal spray Advancia® PF The recently published ‘Pulmonary and Nasal delivery’ magazine includes an article from Nemera:  “Patient Safety: key driver to preservative-free nasal spray development”. In this article, Benoît Guillard, Product Development Leader, Pascale Farjas, Global Category Manager – ENT, and Audrey Chandra, Global Category Manager – Inhalation and Dermal, all of

    Read more
  • WE PUT PATIENTS FIRST

    What does it really mean to put patients first?

    October 21, 2019

    What does it really mean to put patients first? At the global drug delivery company Nemera, the moniker “We Put Patients First” can be seen virtually everywhere. It’s all over the Nemera website, it’s a key part of every PowerPoint deck and it’s even emblazoned on signs and banners throughout their offices at multiple locations. But how is this dedication

    Read more
  • Nemera at PDA The Universe of pre-filled syringes and injection devices 2019

    Can’t wait to meet YOU at PDA The Universe of pre-filled syringes and injection devices!

    October 18, 2019

    Can’t wait to meet YOU at PDA The Universe of pre-filled syringes and injection devices! Nemera will be exhibiting at PDA The Universe of pre-filled syringes and injections devices, which will take place in Gothenburg, Sweden, on October 22-23. Since its first edition in 2004, the PDA conference has become a fixture in the calendar for the pharmaceutical industry, and

    Read more
  • Octobre rose

    October Breast Cancer Awareness Month!

    October 17, 2019

    October Breast Cancer Awareness Month! Breast Cancer Awareness Month is taking place during the month of October, dedicated to the fight against breast cancer. In the world, 1 in 8 women is at risk of developing breast cancer. This event, across the world, helps to increase attention and support for the awareness, early detection and treatment as well as palliative

    Read more
  • Nemera will exhibit at CPHI Worldwide 2019

    Nemera at CPhI Worldwide in Frankfurt!

    October 9, 2019

    Can’t wait to meet YOU at CPhI Worldwide in Frankfurt! Nemera will be one of the 2,500 international exhibitors at the next CPhI Worldwide, which will take place in Frankfurt, on November 5-7. Nemera always puts patients first, providing high-quality solutions that have a demonstrable impact on patients’ health, including off-the-shelf innovative systems, customized design development and GMP contract manufacturing.

    Read more
  • gender equality

    Nemera is committed to Gender Equality

    October 4, 2019

    Nemera is committed to Gender Equality Declared the “most important cause of the next five years” by the President of the French Republic, Gender Equality is at the heart of government priorities. Within this context, new measures were put in place by Decree No. 2019-15 of January 8, 2019, according to which all French companies with more than fifty employees

    Read more
  • Child resistant solutions for nasal and oral sprays

    Nemera launches its NEW Child Resistant solutions!

    October 2, 2019

    Nemera launches its NEW Child Resistant solutions! In collaboration with Roy LeClair, we are happy to announce the launch of its new child resistant spray system for oral and nasal sprays. What are the benefits of this new packaging solution? Wide range of doses Patented child-proof package Ergonomic and contemporary design Compact size for carrying Easy Snap-on cap The different

    Read more
  • image article DDD

    Seen in the press: Nemera’s article featured in ‘Drug Development Delivery’

    September 24, 2019

    “Drug Development Delivery” magazine published an article about the drug delivery impact of design adjustment of Autoinjector.  The recently published “Drug Development Delivery” magazine includes an article about Nemera: “Autoinjector design adjustment to control needle insertion & initial injection speed – could this positively impact drug delivery?”. In this article, Severine Duband, Global Category Manager in the parenteral field, Pascal

    Read more
  • couv

    A new market reference added to Safe’n’Sound®, our passive safety device platform

    September 19, 2019

    A new market reference added to Safe’n’Sound®, our passive safety device platform Safe’n’Sound® is on the market in Europe with a newly registered injectable medication. The commercial launch of HULIO™ (Adalimumab Biosimilar) was initiated in selected European markets on October 19,2018. Hulio, developed by developed by Fujifilm Kyowa Kirin Biologics Co., Ltd. and marketed in the European Union by Mylan

    Read more
  • JW Pharma Advancia OTC South Korea

    A first launch on OTC drugs with Advancia®!

    September 3, 2019

    A first launch on OTC drugs with Advancia®! After the successful launch of Nemera’s next generation nasal spray pump within its Crimp-on version, Advancia Snap-on version is now on the South Korean market with an intranasal decongestant nasal spray. JW Pharmaceutical has recently launched their decongestant range under 2 formats with Advancia Snap-on: Adults and Kids. With its key differentiating

    Read more